Fiche centre
The First Affiliated Hospital of Nanchang University
Nanchang — China
Essais liés6clinical trials
VilleNanchanglocalisation
PaysChinalocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT07767188
Essais cliniques associés
6| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| IPG11406 | Lupus | Phase 1/2 | NCT06717815 | Phase IIa Study for IPG11406 in Patients With Lupus Nephritis | COMPLETED |
| Sotorasib | Cancer | Phase 3 | NCT05920356 | A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202) | RECRUITING |
| Ocrelizumab | SEP | Phase 4 | NCT07483450 | A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Ocrelizumab in Participants With Relapsing Multiple Sclerosis and Primary Progressive Multiple Sclerosis | ACTIVE_NOT_RECRUITING |
| Cizutamig | Lupus | Phase 1 | NCT07215663 | Clinical Study of Cizutamig in Systemic Lupus Erythematosus | RECRUITING |
| obinutuzumab (RO5072759) | Lupus | Phase 3 | NCT07767188 | A Trial to Explore the Efficacy and Safety of O-triple as Initial Therapy in the Active Lupus Nephritis Patients (INITIAL Trial) | NOT_YET_RECRUITING |
| Yangxue Qingnao Granules (Pills) | Migraine | À vérifier | NCT05334927 | CHAIRS — China HeadAche DIsorders RegiStry | RECRUITING |